VCAM1 and nonpapillary renal cell carcinoma: In addition, after normalization by the CTLA-4 (cytotoxic T-lymphocyte-associated Protein 4) gene expression (= ipilimumab target protein), lower expression of VCAM1 mRNA was significantly associated with better prognosis in ccRCC patients (p = 0.012).